Comparing Two Group Therapy Treatments for Binge Eating Disorder
Comparison of Dialectical Behavior Therapy and Supportive Therapy for Binge Eating Disorder
2 other identifiers
interventional
101
1 country
1
Brief Summary
This study will compare two different approaches for the treatment for Binge Eating Disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
October 29, 2003
CompletedFirst Posted
Study publicly available on registry
October 30, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedJune 27, 2013
June 1, 2013
3.8 years
October 29, 2003
June 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
frequency of binge eating
prior 4 weeks
Secondary Outcomes (1)
Emotional Eating Scale
prior 7 days
Study Arms (2)
1
EXPERIMENTALGroup therapy Negative Emotion Focus
2
PLACEBO COMPARATORGroup Psychotherapy- Self Esteem Focus
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of Binge Eating Disorder
- Reside in the San Francisco Bay Area
- Willing to commit to the study requirements
You may not qualify if:
- Unstable medical problems
- History of bipolar illness or schizophrenia
- Receiving treatment for an eating disorder (or unwillingness to discontinue treatment upon study entry)
- Membership in weight-loss groups such as Weight Watchers or Jenny Craig (or unwillingness to discontinue membership upon study entry)
- Use of medications affecting weight or appetite. Antidepressants are acceptable, but doses of any psychiatric medication must have been stable for at least 3 months prior to study start
- Breast-feeding
- Require gastric-bypass surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Stanford University Medical Center
Stanford, California, 94305-5722, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Debra L Safer, MD
Stanford University Dept of Psychiatry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst professor
Study Record Dates
First Submitted
October 29, 2003
First Posted
October 30, 2003
Study Start
October 1, 2003
Primary Completion
July 1, 2007
Study Completion
July 1, 2007
Last Updated
June 27, 2013
Record last verified: 2013-06